Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften E-learning Web-tv Video Audio
Tips voor Mijn BSL
UITGEBREID ZOEKEN
Inloggen
Top
Quality of Life Research
Gepubliceerd in: Quality of Life Research 4/2014

01-05-2014

Validation of a Quality of Life Questionnaire for Bronchiectasis: psychometric analyses of the Spanish QOL-B-V3.0

Auteurs: Casilda Olveira, Gabriel Olveira, Francisco Espildora, Rosa-Maria Giron, Gerard Muñoz, Alexandra L. Quittner, Miguel-Angel Martinez-Garcia

Gepubliceerd in: Quality of Life Research | Uitgave 4/2014

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

Purpose

Bronchiectasis is a chronic disease, leading to worsening of health-related quality of life. This study evaluated the psychometric properties of a new patient-reported outcome for non-cystic fibrosis bronchiectasis, the Quality of Life Questionnaire Bronchiectasis, translated into Spanish (QOL-B-Sp-V3.0).

Methods

This prospective study recruited clinically stable patients with non-cystic fibrosis bronchiectasis at 4 Spanish centers. Health status was assessed with multiple indicators (dyspnea, exacerbations, bronchorrhea, etc.), microbiological, radiological, spirometric, and anthropometric parameters plus St-George Respiratory Questionnaire (SGRQ). Psychometric analyses included internal consistency, test–retest reliability, convergent validity, predictive validity, and responsivity to change.

Results

The 207 stable patients (mean age 57.2 years) had a Bhalla score of 11.53 ± 7.39 and FEV1% of 68.3 ± 22.2 %. One hundred and sixty-one stable patients repeated the test 2 weeks later, and 80 patients who had an exacerbation within 6 months of the assessment also repeated it. Internal consistency was high across all scales (Cronbach’s alpha >0.70). Thirty-six of 37 items correlated more strongly with their assigned scale than a competing scale. Test–retest coefficients were strong (intraclass correlations r = 0.68–0.88). All scales, except Treatment Burden, discriminated significantly between patients with mild, moderate, and severe disease according to FEV1% and other respiratory parameters. Strong convergence was found between the QOL-B-Sp-V3.0 and SGRQ. Significant correlations were found between QOL-B-Sp-V3.0 and various clinical, spirometric, radiological, and anthropometric variables. Significant differences were found on all QOL-B-Sp-V3.0 scales, except emotional functioning, between the baseline responses and onset of an exacerbation; robust sensitivity to change was observed on the Respiratory Symptoms scale.

Conclusions

The QOL-B-Sp-V3.0 questionnaire demonstrated strong reliability and validity. Scores were reproducible after 2 weeks, and it discriminated between patients who varied in severity and was responsive to changes related to exacerbation.
vorige artikel Validating the Migraine-Specific Quality of Life Questionnaire v2.1 (MSQ) in Italian inpatients with chronic migraine with a history of medication overuse
volgende artikel Item reduction of the Wisconsin Upper Respiratory Symptom Survey (WURSS-21) leads to the WURSS-11
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
1.
Vendrell, M., de Gracia, J., Olveira, C., et al. (2008). Diagnosis and treatment of bronchiectasis. Recommendations of The Spanish Society of Pulmonology and Thoracic Surgery (SEPAR). Archivos de Bronconeumologia, 44, 629–640.PubMedCrossRef
2.
Pasteur, M. C., Bilton, D., Hill, A. T., & On behalf of the British Thoracic Society Bronchiectasis (non-CF) Guidelines Group. (2010). British Thoracic Society for non-CF bronchiectasis. Thorax, 65, i1–i58.PubMedCrossRef
3.
O’Leary, C. J., Wilson, C. B., Hansell, D. M., Cole, P. J., Wilson, R., & Jones, P. W. (2002). Relationship between psychological well-being and lung health status in patients with bronchiectasis. Respiratory Medicine, 96, 686–692.PubMedCrossRef
4.
Olveira, C., Olveira, G., Gaspar, I., et al. (2013). Depression and anxiety symptoms in bronchiectasis: associations with health-related quality of life. Quality of Life Research, 22, 597–605.PubMedCrossRef
5.
Olveira, G., Olveira, C., Gaspar, I., et al. (2010). Validation of the Spanish version of the revised cystic fibrosis quality of life questionnaire in adolescents and adults (CFQR 14 + Spain). Archivos de Bronconeumologia, 46, 165–175.PubMed
6.
Quittner, A. L., Buu, A., Messer, M. A., Modi, A. C., & Watrous, M. (2005). Development and validation of The Cystic Fibrosis Questionnaire in the United States: A health-related quality-of-life measure for cystic fibrosis. Chest Journal, 128, 2347–2354.CrossRef
7.
8.
Jones, P. W., Quirk, F. H., Baveystock, C. M., & Littlejohns, P. (1992). A self-complete measure of health status for chronic airflow limitation: The St. George’s Respiratory Questionnaire. American Journal of Respiratory and Critical Care Medicine, 145, 1321–1327.
9.
Padilla, A., Olveira, G., Olveira, C., et al. (2007). Validity and reliability of the St George’s Respiratory Questionnaire in adults with cystic fibrosis. Archivos de Bronconeumologia, 43, 205–211.PubMedCrossRef
10.
Martínez-García, M. A., Perpiñá Tordera, M., Román Sánchez, P., & Soler Cataluña, J. J. (2005). Internal consistency and validity of the Spanish version of the St. George’s respiratory questionnaire for use in patients with clinically stable bronchiectasis. Archivos de Bronconeumologia, 41, 110–117.PubMed
11.
Retsch-Bogart, G. Z., Quittner, A. L., Gibson, R. L., et al. (2009). Efficacy and safety of inhaled aztreonam lysine for airway pseudomonas in cystic fibrosis. Chest Journal, 135, 1223–1232.CrossRef
12.
Martínez-García, M. A., Perpiñá-Tordera, M., Román-Sánchez, P., & Soler-Cataluña, J. J. (2005). Quality-of-life determinants in patients with clinically stable bronchiectasis. Chest Journal, 128, 739–745.CrossRef
13.
Wilson, C. B., Jones, P. W., O’Leary, C. J., Hansell, D. M., Cole, P. J., & Wilson, R. (1997). Effect of sputum bacteriology on the quality of life of patients with bronchiectasis. European Respiratory Journal, 10, 1754–1760.PubMedCrossRef
14.
Chan, S. L., Chan-Yeung, M. M., Ooi, G. C., et al. (2002). Validation of the Hong Kong Chinese version of the St. George Respiratory Questionnaire in patients with bronchiectasis. Chest Journal, 122, 2030–2037.CrossRef
15.
Jones, P. W. (2002). Interpreting thresholds for a clinically significant change in health status in asthma and COPD. European Respiratory Journal, 19, 398–404.PubMedCrossRef
16.
Martínez-García, M. A., Soler-Cataluña, J. J., Catalán-Serra, P., Román-Sánchez, P., & Tordera, M. P. (2012). Clinical efficacy and safety of budesonide formoterol in non-cystic fibrosis BQ. Chest Journal, 141, 461–468.CrossRef
17.
Murray, M. P., Turnbull, K., Mac Quarrie, S., Pentland, J. L., & Hill, A. T. (2009). Validation of the Leicester Cough Questionnaire in non-cystic fibrosis bronchiectasis. European Respiratory Journal, 34, 125–131.PubMedCrossRef
18.
Reda, A. A., Kotz, D., Kocks, J. W., Wesseling, G., & Van Schayck, C. P. (2010). Reliability and validity of the clinical COPD questionnaire and chronic respiratory questionnaire. Respiratory Medicine, 104, 1675–1682.PubMedCrossRef
19.
Quittner, A. L., Cruz, I., Marciel, K. K., Ilowite, J., Gotfried, M. H., & Barker, A. (2009). A new PRO for non-CF bronchiectasis: Associations between the QOL-B and health outcomes. [Abstract]. European Respiratory Journal, 34(Suppl. 53), 1010.
20.
Quittner, A. L., Salathe, M., Gotfried, M., et al. (2010). National validation of a patient-reported outcome measure for bronchiectasis: Psychometric results on the QOL-B.[Abst.] American Journal of Respiratory Critical Care Medicine A5793. www.​atsjournals.​org Online Abstracts Issue.
21.
Quittner, A. L. (2012). Development of a disease-specific PRO for non-CF bronchiectasis: The QOL-B FDA Workshop 2012.
22.
Naidich, D. P., McCauley, D. I., Khouri, N. F., Stitik, F. P., & Siegelman, S. S. (1982). Computed tomography of bronchiectasis. Journal of Computer Assisted Tomography, 6, 437–444.PubMedCrossRef
23.
Rosenstein, B. J., & Cutting, G. R. (1998). The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel. Journal of Pediatrics, 132, 589–595.PubMedCrossRef
24.
Medical Research Council. (1982). Committee on research into chronic bronchitis: Instruction for use on the questionnaire on respiratory symptoms. In S. M. Brooks (Ed.), Surveillance for respiratory hazards (Vol. 8, pp. 12–16). ATS News. Devon: WJ Holman 1966.
25.
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987). A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal of Chronic Disease, 40, 373–383.CrossRef
26.
Roca, J., Sanchis, J., Agustí Vidal, A., et al. (1986). Spirometric reference values for a Mediterranean population. Bulletin Européen de Physiopathologie Respiratoire, 22, 217–224.PubMed
27.
Bhalla, M., Turcios, N., Aponte, V., et al. (1991). Cystic fibrosis: Scoring system with thin-section CT. Radiology, 179, 783–788.PubMed
28.
Snider, G. L., Kory, R. C., & Lyons, H. A. (1967). Grading of pulmonary function impairment by means of pulmonary function test. Diseases of the Chest, 52, 270–271.CrossRef
29.
Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale, NJ: Erlbaum Associates.
30.
Quittner, A. L., Avani Modi, A. C., Wainwright, C., Otto, K., Kirihara, J., & Montgomery, B. (2009). Determination of the minimal clinically important difference scores for the Cystic Fibrosis Questionnaire-revised respiratory symptom scale in two populations of patients with cystic fibrosis and chronic Pseudomonas aeruginosa airway infection. Chest Journal, 135, 1610–1618.CrossRef
31.
Quittner, A. L., Sawicki, G. S., Mc Mulen, A., et al. (2012). Psychometric evaluation of the Cystic Fibrosis Questionnaire-revised in a national US simple. Quality of Life Research, 21, 1279–1290.PubMedCrossRef
32.
Schmidt, A., Wenninger, K., Niemann, N., Wahn, U., & Staab, D. (2009). Health-related quality of life in children with cystic fibrosis: Validation of the German CFQ-R. Health and Quality of Life Outcomes, 7, 97.PubMedCentralPubMedCrossRef
33.
Bregnballe, V., Thastum, M., Lund, L., Hansen, C. R., Preissler, T., & Schiøtz, P. O. (2008). Validation of the Danish version of the revised cystic fibrosis quality of life questionnaire in adolescents and adults (CFQ-R14+). Journal of Cystic Fibrosis, 7, 531–536.PubMedCrossRef
34.
Wilson, C. B., Jones, P. W., O’Leary, C. J., Cole, P. J., & Wilson, R. (1997). Validation of the St George’s Respiratory Questionnaire in bronchiectasis. American Journal of Respiratory and Critical Care Medicine, 156, 536–541.PubMedCrossRef
35.
Olveira, G., Olveira, C., Gaspar, I., et al. (2011). Malnutrition and inflammation in patients with bronchiectasis. Clinical Nutrition, 6(suppl 1), 150–151.
36.
Olveira, G., Olveira, C., Gaspar, I., et al. (2012). Fat-free mass depletion and inflammation in patients with bronchiectasis. Journal of the Academy of Nutrition and Dietetics, 112, 1999–2006.PubMedCrossRef
37.
Olveira, G., Olveira, C., Dorado, A., et al. (2013). Cellular and plasma oxidative stress biomarkers are raised in adults with bronchiectasis. Clinical Nutrition, 32, 112–117.PubMedCrossRef
Metagegevens
Titel
Validation of a Quality of Life Questionnaire for Bronchiectasis: psychometric analyses of the Spanish QOL-B-V3.0
Auteurs
Casilda Olveira
Gabriel Olveira
Francisco Espildora
Rosa-Maria Giron
Gerard Muñoz
Alexandra L. Quittner
Miguel-Angel Martinez-Garcia
Publicatiedatum
01-05-2014
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 4/2014
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-013-0560-0

Andere artikelen Uitgave 4/2014

Quality of Life Research 4/2014 Naar de uitgave

OriginalPaper

Development and testing of item response theory-based item banks and short forms for eye, skin and lung problems in sarcoidosis

OriginalPaper

Measurement properties of the Adolescent Quality of Life Mental Health Scale (AQOL-MHS)

OriginalPaper

A cross-sectional study of psychological complaints and quality of life in severely injured patients

Review

Oral Chinese herbal medicine for improvement of quality of life in patients with chronic heart failure: a systematic review and meta-analysis

OriginalPaper

Validation and comparison of 15-D and EQ-5D-5L instruments in a Spanish Parkinson’s disease population sample

Brief Communication

Validating the Migraine-Specific Quality of Life Questionnaire v2.1 (MSQ) in Italian inpatients with chronic migraine with a history of medication overuse